CSBR

Champions Oncology Inc.

Price

$5.00

return (12m)

-24.47%

p/e

-58.97

p/bv

17.10

DIVIDEND YIELD

0.00%

CSBR price

Champions Oncology

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CSBR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.71%

3 months

-14.31%

1 year

-24.47%

2 years

11.11%

5 years

-49.95%

10 years

214.47%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CSBR

Valuation

P/E

-58.97

Sector -0.16

Industry 2.77

P/BV

17.10

Sector 1.93

Industry 2.37

P/Revenue (PSR)

1.17

Sector 1.67

Industry 1.97

EV/EBITDA

Sector -55.30

Industry -73.25

EV/EBIT

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

2.58

Sector 0.91

Industry 1.07

P/Net Current Assets

-18.81

Sector -24.70

Industry -5.25

P/Working Capital

-99.40

Sector -5.32

Industry 3.11

EPS

-0.08

Sector -0.79

Industry -0.61

BVPS

0.29

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

47.99%

Sector 48.28%

Industry 50.49%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

0.00%

Sector -62.93%

Industry -21.31%

Operating Margin

-1.94%

Sector -23.12%

Industry -27.36%

Net Profit Margins

-1.99%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.51

Sector 0.13

Industry 0.15

Profitability

ROE

-28.99%

Sector -31.93%

Industry -27.86%

ROA

-4.37%

Sector -28.25%

Industry -27.56%

ROIC

0.00%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.96

Sector 1.85

Industry 1.98

Net Debt / EBITDA

Sector -42.46

Industry -72.45

Net Debt / EBIT

Sector -37.26

Industry -7.11

Net Debt / Equity

0.00

Sector -1.04

Industry -0.12

Gross Debt / Equity

0.00

Sector -0.72

Industry 0.10

Equity/Assets

0.15

Sector 0.43

Industry 0.45

Liabilities/Assets

0.85

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

6.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals CSBR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CSBR Champions Oncology Inc.	$5.00	-24.24%	0.00%	-58.97	17.10	-28.99%	-1.99%
TMO Thermo Fisher Scientific Inc.	$618.91	27.34%	0.29%	33.36	4.42	13.26%	15.08%
DHR Danaher Corporation	$215.43	5.71%	0.67%	37.88	2.88	7.61%	15.95%
WAT Waters Corporation	$413.55	38.94%	0.00%	244.98	2.68	1.09%	3.58%
IQV IQVIA Holdings Inc.	$261.90	38.72%	0.00%	31.33	6.86	21.89%	8.12%
SHC Sotera Health Company	$19.32	17.09%	0.00%	33.54	8.24	24.56%	13.44%
CGEN Compugen Ltd.	$2.62	77.89%	0.00%	6.99	2.77	39.65%	47.54%
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
LLY Eli Lilly and Compay	$1,169.97	61.21%	0.52%	41.58	-	-%	33.53%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
SNY Sanofi	$44.84	-7.34%	3.87%	7.43	1.37	18.43%	13.81%
NVS Novartis AG	$153.04	22.95%	1.96%	28.21	7.75	27.47%	26.57%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
GSK GlaxoSmithKline PLC	$50.24	31.67%	3.42%	15.92	4.50	28.24%	14.54%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
HCA HCA Healthcare Inc.	$419.06	4.14%	0.70%	12.08	-29.56	-244.72%	10.07%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CSBR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Champions Oncology

Champions Oncology Inc.

Average Investor10 user rating

4.0 (1 people)

United States

41 years

Founded: 1985

2007

Time since IPO - 19 years

143

Employees

Champions Oncology Inc. (United States) is listed on the Nasdaq and has a market capitalization of $69.58 million, with shareholders equity totaling $4.07 million.

The company employs approximately 143 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Champions Oncology Inc. reported $59.43 million in revenue, generating net income of $-1.18 million.

Key financial metrics include a P/E ratio of -58.97, a price-to-book (P/B) ratio of 17.10, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CSBR.

Market cap

$69.58 million

Net worth

$4.07 million

$4,070,000.00

Assets

$26.99 million

$26,990,000.00

Total Shares Outstanding

14.00 million

14,000,000

Average Daily Trading Volume

$9.32 Thousand

$9,315.90

Sector

Health

Industry

Life Science Tools and Services

CSBR

CSBR revenue and profits

Financial Results CSBR

DRAG THE FRAME TO SEE MORE DATA

CSBR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75